ArticleCancers2025

Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis.

Buket Şahin Çelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.